Raras
Buscar doenças, sintomas, genes...
Doença de Tangier
ORPHA:31150CID-10 · E78.6CID-11 · 5C81.0OMIM 205400DOENÇA RARA

A doença de Tânger (DT) é um distúrbio raro do metabolismo das lipoproteínas, caracterizado bioquimicamente por uma ausência quase completa de lipoproteínas de alta densidade (HDL) plasmáticas e, clinicamente, por aumento do fígado, baço, linfonodos e amígdalas, juntamente com neuropatia periférica em crianças e adolescentes e, ocasionalmente, doença cardiovascular em adultos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A doença de Tânger (DT) é um distúrbio raro do metabolismo das lipoproteínas, caracterizado bioquimicamente por uma ausência quase completa de lipoproteínas de alta densidade (HDL) plasmáticas e, clinicamente, por aumento do fígado, baço, linfonodos e amígdalas, juntamente com neuropatia periférica em crianças e adolescentes e, ocasionalmente, doença cardiovascular em adultos.

Publicações científicas
589 artigos
Último publicado: 2026 Mar 12

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
185
pacientes catalogados
Início
Adolescent
+ adult, childhood, infancy, neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: E78.6
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (6)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
4 sintomas
🩸
Sangue
3 sintomas
😀
Face
3 sintomas
❤️
Coração
3 sintomas
👁️
Olhos
3 sintomas
💪
Músculos
2 sintomas

+ 17 sintomas em outras categorias

Características mais comuns

90%prev.
Hipertrigliceridemia
Muito frequente (99-80%)
90%prev.
Hipocolesterolemia
Muito frequente (99-80%)
55%prev.
Dor abdominal
Frequente (79-30%)
55%prev.
Estenose da artéria coronária
Frequente (79-30%)
55%prev.
Hepatoesplenomegalia
Frequente (79-30%)
55%prev.
Distrofia ungueal
Frequente (79-30%)
39sintomas
Muito frequente (2)
Frequente (12)
Ocasional (8)
Sem dados (17)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 39 características clínicas mais associadas, ordenadas por frequência.

HipertrigliceridemiaHypertriglyceridemia
Muito frequente (99-80%)90%
HipocolesterolemiaHypocholesterolemia
Muito frequente (99-80%)90%
Dor abdominalAbdominal pain
Frequente (79-30%)55%
Estenose da artéria coronáriaCoronary artery stenosis
Frequente (79-30%)55%
HepatoesplenomegaliaHepatosplenomegaly
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico589PubMed
Últimos 10 anos103publicações
Pico202514 papers
Linha do tempo
2026Hoje · 2026🧪 1986Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

ABCA1Phospholipid-transporting ATPase ABCA1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Catalyzes the translocation of specific phospholipids from the cytoplasmic to the extracellular/lumenal leaflet of membrane coupled to the hydrolysis of ATP (PubMed:24097981, PubMed:35974019). Thereby, participates in phospholipid transfer to apolipoproteins to form nascent high density lipoproteins/HDLs (PubMed:14754908). Transports preferentially phosphatidylcholine over phosphatidylserine (PubMed:24097981). May play a similar role in the efflux of intracellular cholesterol to apolipoproteins

LOCALIZAÇÃO

Cell membraneEndosome

VIAS BIOLÓGICAS (2)
PPARA activates gene expressionNR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
MECANISMO DE DOENÇA

Tangier disease

An autosomal recessive disorder characterized by near absence of plasma high density lipoproteins, low serum HDL cholesterol, and massive tissue deposition of cholesterol esters. Clinical features include large yellow-orange tonsils, hepatomegaly, splenomegaly, enlarged lymph nodes, and often sensory polyneuropathy.

OUTRAS DOENÇAS (2)
hypoalphalipoproteinemia, primary, 1Tangier disease
HGNC:29UniProt:O95477

Variantes genéticas (ClinVar)

198 variantes patogênicas registradas no ClinVar.

🧬 ABCA1: NM_005502.4(ABCA1):c.1804C>T (p.Gln602Ter) ()
🧬 ABCA1: NM_005502.4(ABCA1):c.843dup (p.Arg282fs) ()
🧬 ABCA1: NM_005502.4(ABCA1):c.847C>T (p.Gln283Ter) ()
🧬 ABCA1: NM_005502.4(ABCA1):c.1265del (p.Lys422fs) ()
🧬 ABCA1: NM_005502.4(ABCA1):c.1758dup (p.Arg587fs) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 284 variantes classificadas pelo ClinVar.

114
170
Patogênica (40.1%)
VUS (59.9%)
VARIANTES MAIS SIGNIFICATIVAS
ABCA1: NM_005502.4(ABCA1):c.5383-2A>T [Likely pathogenic]
ABCA1: NM_005502.4(ABCA1):c.1979del (p.Val660fs) [Pathogenic]
ABCA1: NM_005502.4(ABCA1):c.2302C>T (p.Gln768Ter) [Pathogenic]
ABCA1: NM_005502.4(ABCA1):c.3103+1G>C [Likely pathogenic]
ABCA1: NM_005502.4(ABCA1):c.3584G>A (p.Arg1195Gln) [Conflicting classifications of pathogenicity]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 33
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de Tangier

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

6 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
103 papers (10 anos)
#1

Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N-of-1 Trial with 21 months Clinical Observation.

Neurology and therapy2026 Feb

Tangier disease (TD) is an ultra-rare disease, characterised by progressive peripheral neuropathy with no established treatment. To determine whether miglustat improved the clinical status of a single patient with TD, and to investigate the possible mechanisms of miglustat in this patient. An n-of-1 ABAB study, alternating on and off treatment for 6-month periods, total study duration of 2 years with an additional compassionate-access period of 21 months. Miglustat, an orphan drug licenced to treat Gaucher disease and Niemann-Pick disease, was repurposed. The study was designed with two co-primary endpoints: (a) time taken to complete the nine-hole peg test (fine motor control and finger dexterity), and (b) hand strength: grip and three-point pinch strength tests. Secondary endpoints were quality-of-life measures and biomarkers. A 21-year-old (at baseline) left-handed male patient with TD, diagnosed at the age of 6 months, and disabling neuropathy was included in the study. Over 2 years, there was a small signal in our clinical measures that the drug may be beneficial. Compared with the 2 years prior to treatment, the patient had no relapse of neuropathy during his study period and further extension. During the 21-month treatment extension, he showed considerable improvement on primary endpoints. Biomarkers changed as expected based on the mechanism of action of miglustat. Nerve conduction studies showed a mild benefit. Importantly, the patient's reported experience suggested a meaningful benefit from miglustat. Miglustat may be used to treat neurological complications of TD. This study showed that an n-of-1 study to inform a policy decision is practical and may offer hope to patients with rare diseases. ClinicalTrials.gov Identifier: ISRCTN17945917. Registration date: 07/06/2021; 'retrospectively registered'.

#2

Correction: Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N‑of‑1 Trial with 21 months Clinical Observation.

Neurology and therapy2026 Mar 12
#3

ABCA1: A Therapeutic Target for Improving Cholesterol Homeostasis in Peripheral Neuropathies.

Biomolecules2026 Feb 22

ATP-binding cassette A1 (ABCA1) is a critical molecule in facilitating cholesterol transport in a variety of organs. In the nervous system, cholesterol supply is essential and rate-limiting for myelin biogenesis, which underlies efficient conduction of nerve impulses. When myelin is damaged or improperly formed due to genetic defects, a host of neurological symptoms may arise. A rare form of peripheral neuropathy in Tangier disease (TD) patients is associated with autosomal recessive mutations in ABCA1. Accordingly, when ABCA1 loses its function due to misexpression, the neuropathic phenotype is over-represented. Independently, studies have revealed the altered expression of ABCA1 and dysregulation of cholesterol metabolism in a host of inherited peripheral neuropathies engaging the Peripheral Myelin Protein 22 (PMP22), suggesting shared pathophysiology. While the role of ABCA1 has not been investigated broadly in peripheral nerves, the transporter molecule is a therapeutic target for human disorders, including multiple sclerosis and Alzheimer's disease. Investigations in rodent models of type 1 Charcot-Marie-Tooth (CMT) neuropathies support the candidacy of this cholesterol transporter as a therapeutic target in efforts of peripheral myelin repair. Ongoing preclinical studies in central and peripheral nervous system disease models will provide critical information on the importance of ABCA1 as a target for disease modifying intervention.

#4

A Novel Missense Mutation in a Compound Heterozygous Patient with Fish-Eye Disease: A Case Report.

Case reports in ophthalmology2026

Fish-eye disease (FED) is a rare autosomal recessive disorder caused by a partial deficiency of lecithin-cholesterol acyltransferase (LCAT) activity. It is characterized by progressive corneal opacification and dyslipidemia in the absence of systemic manifestations. We describe the clinical presentation, optical coherence tomography (OCT) imaging findings, and Scheimpflug-based corneal densitometry results in a patient with FED carrying both a pathogenic variant and a novel missense variant of the LCAT gene not reported in the current literature. We present a rare case of a 25-year-old female with bilateral corneal opacities, reduced plasma high-density lipoprotein cholesterol (<5 mg/dL), and elevated low-density lipoprotein cholesterol levels (>133 mg/dL). Visual acuity remained 20/20 in both eyes. Slit-lamp examination revealed diffuse subepithelial and anterior stromal deposits. The central corneal thickness was thinner than normal on Scheimpflug tomography, measuring 419 µm OD and 409 µm OS. OCT findings confirmed stromal thinning (479 µm OD and 470 µm OS), with preserved central epithelial thickness, and demonstrated corneal opacities throughout the cornea. Mean densitometry across the 12-mm corneal diameter was more than double that reported in healthy corneas. The cholesteryl ester-to-total cholesterol ratio remained within the normal range. Genetic analysis identified a previously reported pathogenic variant in exon 4 of LCAT (c.440C>T, p.Thr147Ile) and a novel missense mutation in exon 5 (c.715G>A, p.Gly239Ser), classified as a variant of uncertain significance. FED is a rare genetic disorder that is associated with corneal clouding and dyslipidemia. Genetic analysis confirmed the diagnosis with a compound heterozygous genotype, while OCT and corneal densitometry were effective modalities for quantifying and characterizing lipid deposits in FED.

#5

A novel ABCA1 variant associated with impaired platelet production contributing to thrombocytopenia in a family with Tangier disease.

Journal of clinical lipidology2026 Feb

ATP-binding cassette A1 (ABCA1) is a membrane-associated cholesterol efflux pump that is crucial for high-density lipoprotein (HDL) biogenesis and cellular cholesterol homeostasis. Pathogenic variants in the ABCA1 gene cause Tangier disease (TD), a rare autosomal recessive disorder characterized by nearly absent HDL in plasma and cholesteryl ester accumulation in tissue macrophages. Clinical manifestations vary among patients with TD, including splenomegaly, thrombocytopenia, and cardiovascular disease (CVD), with no clear association with specific ABCA1 pathogenic variants. Thrombocytopenia is attributed to hypersplenism-mediated platelet clearance; however, there is controversy regarding platelet production and function in TD. To identify and functionally characterize the suspected alteration in ABCA1, and to study platelet production and function in a Spanish family with HDL deficiency and thrombocytopenia. Lipid and apolipoprotein profile analyses, next-generation/Sanger sequencing, in vitro ABCA1 expression and cholesterol efflux assays, primary megakaryocyte differentiation cultures, and platelet functional studies were performed. We identified a novel variant, ABCA1:NM_005502.4c.3306del:p.(Ile1103Serfs*16), which results in a truncated protein with defective apolipoprotein AI-dependent cholesterol efflux. Mild to severe thrombocytopenia and splenomegaly were observed in homozygous carriers; however, there was no clinical history of CVD. Platelet degranulation was overtly normal, although a distinct aggregation profile was observed in ABCA1:p.(Ile1103Serfs*16) carriers. Impaired megakaryocyte differentiation associated with aberrant accumulation of neutral lipids in megakaryocytes was observed in primary cell cultures from homozygous carriers. The ABCA1:NM_005502.4c.3306del:p.(Ile1103Serfs*16) variant causes TD. Our findings suggest that thrombocytopenia in TD is not merely due to platelet clearance but also a consequence of ineffective megakaryopoiesis due to ABCA1 dysfunction.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC273 artigos no totalmostrando 100

2026

ABCA1: A Therapeutic Target for Improving Cholesterol Homeostasis in Peripheral Neuropathies.

Biomolecules
2026

A Novel Missense Mutation in a Compound Heterozygous Patient with Fish-Eye Disease: A Case Report.

Case reports in ophthalmology
2026

A novel ABCA1 variant associated with impaired platelet production contributing to thrombocytopenia in a family with Tangier disease.

Journal of clinical lipidology
2025

Assessing rare disease understanding: a novel disease readiness level framework.

Orphanet journal of rare diseases
2025

Deficiency of the Tangier Disease Gene Abca1 Is Associated With Microglial Defects in Mice.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2026

Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N-of-1 Trial with 21 months Clinical Observation.

Neurology and therapy
2025

A novel ABCA1 mutation in Tangier disease associated with severe premature and rapidly progressive neurodegenerative disorder.

Journal of clinical lipidology
2025

Progressive histiocytosis in Tangier disease: a 17-year follow-up.

Pathology
2025

Functional characterization of genetic variants affecting the intracellular domains of ATP-binding cassette transporter A1 (ABCA1).

Journal of lipid research
2025

Is Tangier disease a rare cause of premature ovarian insufficiency?: A case report.

Journal of clinical lipidology
2025

Quantitative Sensory Testing in a Girl With Tangier Disease: A Case Report.

Cureus
2025

Expect the unexpected: Tangier disease and monoclonal gammopathy of undetermined significance.

British journal of haematology
2025

Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization.

The Journal of clinical endocrinology and metabolism
2025

A novel variant in the ABCA1 gene for Tangier Disease with diffuse histiocytosis of bone marrow.

Journal of clinical lipidology
2025

The clinical presentation and genetic diagnosis of Tangier disease in the pediatric age group.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Primary Hypoalphalipoproteinemia With Significant Premature Atherosclerosis.

JACC. Case reports
2025

Novel pathogenic variant in the LCAT gene in a compound heterozygous patient with fish-eye disease and a mild phenotype.

Journal of clinical lipidology
2024

[Homozygous ABCA1 gene mutated Tangier disease complicated with diabetes mellitus: a case report].

Zhonghua nei ke za zhi
2024

A novel splicing variant in ABCA1 in the first reported Hong Kong Chinese patient with high-density lipoprotein deficiency.

Endocrinology, diabetes &amp; metabolism case reports
2024

ABCA1 deficiency causes tissue-specific dysregulation of the SREBP2 pathway in mice.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2024

ATP-Binding Cassette Transporter of Clinical Significance: Sideroblastic Anemia.

Journal of personalized medicine
2024

Genetic and Functional Analyses of Patients with Marked Hypo-High-Density Lipoprotein Cholesterolemia.

Journal of atherosclerosis and thrombosis
2025

Role of ABCA1 in Atherosclerosis: Novel Mutations and Potential Plant-derived Therapies.

Current medicinal chemistry
2024

A case report of Tangier disease presents with acute sensorimotor polyneuropathy and its treatment approach.

Journal of clinical lipidology
2024

Functional characterization of missense variants affecting the extracellular domains of ABCA1 using a fluorescence-based assay.

Journal of lipid research
2023

Interpreting New Thoughts on HDL Through the Lens of Chesapeake Bay's Tangier Disease.

Journal of community hospital internal medicine perspectives
2023

The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.

Biochemical Society transactions
2023

Atypical Presentation of Tangier Disease-Expanding the Clinical Spectrum.

Journal of clinical neuromuscular disease
2023

Hepatocyte ABCA1 deficiency is associated with reduced HDL sphingolipids.

Frontiers in physiology
2023

ABCA1 Deficiency: A Rare Cause of Premature Coronary Artery Disease.

JACC. Case reports
2022

Rare primary dyslipidaemias associated with low LDL and HDL cholesterol values in Portugal.

Frontiers in genetics
2023

Association of a Novel Homozygous Variant in ABCA1 Gene with Tangier Disease.

Journal of clinical medicine
2023

Early-onset atherosclerosis in a patient with Tangier disease: Not all that is gold glitters.

Kardiologia polska
2023

Biomedical Advances in ABCA1 Transporter: From Bench to Bedside.

Biomedicines
2023

Very low HDL levels: clinical assessment and management.

Archives of endocrinology and metabolism
2023

A rare case of nephrotic syndrome and Tangier disease.

CEN case reports
2022

HDL, cholesterol efflux, and ABCA1: Free from good and evil dualism.

Journal of pharmacological sciences
2022

Sensory-motor not length-dependent multineuropathy followed by the syringomyelia-like phenotype: a novel presentation of Tangier disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.

Advances in experimental medicine and biology
2022

A case of mesenteric panniculitis in a patient with Tangier disease.

Journal of clinical lipidology
2022

Cholesterol efflux mechanism revealed by structural analysis of human ABCA1 conformational states.

Nature cardiovascular research
2021

Tangier Disease: An Unusual Cause of Chronic Diarrhea.

ACG case reports journal
2022

Prospective Registry Study of Primary Dyslipidemia (PROLIPID): Rationale and Study Design.

Journal of atherosclerosis and thrombosis
2021

Current Diagnosis and Management of Tangier Disease.

Journal of atherosclerosis and thrombosis
2021

Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk.

Atherosclerosis
2021

The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.

International journal of molecular sciences
2021

A case of premature and recurrent myocardial infarction associated with ABCA.1 gene mutation.

Journal of postgraduate medicine
2020

[Tangier disease in family with the phenotype of familial hypercholesterolemia].

Vnitrni lekarstvi
2021

Unusual White-Yellowish Dots in the Colon Reveal a Rare Metabolic Disease.

Gastroenterology
2021

The ABCs of Sterol Transport.

Annual review of physiology
2021

Orphan Peripheral Neuropathies.

Journal of neuromuscular diseases
2020

The impact of ATP-binding cassette transporters on metabolic diseases.

Nutrition &amp; metabolism
2020

Human Insulin Growth Factor 2 mRNA Binding Protein 2 Increases MicroRNA 33a/b Inhibition of Liver ABCA1 Expression and Alters Low-Density Apolipoprotein Levels in Mice.

Molecular and cellular biology
2020

Tangier disease: update for 2020.

Current opinion in lipidology
2019

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.

Biomolecules
2020

Mechanistic convergence and shared therapeutic targets in Niemann-Pick disease.

Journal of inherited metabolic disease
2019

[Inborn errors of high-density lipoprotein metabolism].

Der Internist
2019

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

The Journal of clinical investigation
2019

Functionally Significant Features in the 5' Untranslated Region of the ABCA1 Gene and Their Comparison in Vertebrates.

Cells
2019

Nerve high-resolution ultrasonography in tangier disease.

Muscle &amp; nerve
2019

A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.

Biochemical and biophysical research communications
2019

Ocular and Genetic Characteristics Observed in Two Cases of Fish-Eye Disease.

Cornea
2018

Identification of the first Tangier disease patient in Lebanon carrying a new pathogenic variant in ABCA1.

Journal of clinical lipidology
2018

ATP binding cassette family A protein 1 determines hexosylceramide and sphingomyelin levels in human and mouse plasma.

Journal of lipid research
2018

Tangier disease may cause early onset of atherosclerotic cerebral infarction: A case report.

Medicine
2018

A novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia.

Journal of clinical lipidology
2018

Undetectable high-density lipoprotein cholesterol in acute malaria.

Journal of clinical lipidology
2018

Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.

Circulation
2018

Peripheral neuropathy in Tangier disease: A literature review and assessment.

Journal of the peripheral nervous system : JPNS
2018

Accelerated Atherogenicity in Tangier Disease.

Journal of atherosclerosis and thrombosis
2018

ATP-binding cassette transporter A1: A promising therapy target for prostate cancer.

Molecular and clinical oncology
2018

Unusual yellow scaly colonic mucosal appearance: Tangier disease.

Gastrointestinal endoscopy
2018

Can Tangier disease cause male infertility? A case report and an overview on genetic causes of male infertility and hormonal axis involved.

Molecular genetics and metabolism
2017

Steryl ester synthesis, storage and hydrolysis: A contribution to sterol homeostasis.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2017

[Valve Replacement for Severe Aortic Stenosis in a Patient with Tangier Disease].

Kyobu geka. The Japanese journal of thoracic surgery
2017

Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Biochimica et biophysica acta. Molecular and cell biology of lipids
2017

The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: A case report.

Clinical biochemistry
2017

Reduced platelet count, but no major platelet function abnormalities, are associated with loss-of-function ATP-binding cassette-1 gene mutations.

Clinical science (London, England : 1979)
2017

Structure of the Human Lipid Exporter ABCA1.

Cell
2017

Clinical utility gene card for: Tangier disease.

European journal of human genetics : EJHG
2017

The iPSC Awakens ANGPTL3 in Tangier Disease.

EBioMedicine
2017

ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion.

EBioMedicine
2017

Methods for Monitoring ABCA1-Dependent Sterol Release.

Methods in molecular biology (Clifton, N.J.)
2016

A Novel Mutation in ABCA1 Gene Causing Tangier Disease in an Italian Family with Uncommon Neurological Presentation.

Frontiers in neurology
2016

Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly.

Biochimica et biophysica acta
2016

Diagnosis and treatment of high density lipoprotein deficiency.

Progress in cardiovascular diseases
2016

Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases.

Nutrition &amp; metabolism
2016

Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.

Annals of Indian Academy of Neurology
2016

ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1.

Journal of thrombosis and haemostasis : JTH
2015

An uncommon cause of bifacial weakness and non-length-dependent demyelinating neuropathy.

Annals of Indian Academy of Neurology
2016

Subfraction analysis of circulating lipoproteins in a patient with Tangier disease due to a novel ABCA1 mutation.

Clinica chimica acta; international journal of clinical chemistry
2016

Update on the molecular biology of dyslipidemias.

Clinica chimica acta; international journal of clinical chemistry
2015

Clinical, Electrodiagnostic, and Genetic Features of Tangier Disease in an Adolescent Girl with Presentation of Peripheral Neuropathy.

Neuropediatrics
2015

The Role of Cardiolipin in Cardiovascular Health.

BioMed research international
2015

Deficiency in the Lipid Exporter ABCA1 Impairs Retrograde Sterol Movement and Disrupts Sterol Sensing at the Endoplasmic Reticulum.

The Journal of biological chemistry
2015

Extreme clinical chemistry.

Clinica chimica acta; international journal of clinical chemistry
2015

ABCA1 and Inflammation: From Animal Models to Humans.

Arteriosclerosis, thrombosis, and vascular biology
2015

Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.

Circulation research
2015

Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.

Atherosclerosis
2015

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

Circulation research
Ver todos os 273 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de Tangier.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença de Tangier

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N-of-1 Trial with 21&#xa0;months Clinical Observation.
    Neurology and therapy· 2026· PMID 41212481mais citado
  2. Correction: Miglustat as a Treatment for Adults with Tangier Disease Neuropathy: The MUSTANG N&#x2011;of&#x2011;1 Trial with 21&#xa0;months Clinical Observation.
    Neurology and therapy· 2026· PMID 41817649mais citado
  3. ABCA1: A Therapeutic Target for Improving Cholesterol Homeostasis in Peripheral Neuropathies.
    Biomolecules· 2026· PMID 41750400mais citado
  4. A Novel Missense Mutation in a Compound Heterozygous Patient with Fish-Eye Disease: A Case Report.
    Case reports in ophthalmology· 2026· PMID 41635805mais citado
  5. A novel ABCA1 variant associated with impaired platelet production contributing to thrombocytopenia in a family with Tangier disease.
    Journal of clinical lipidology· 2026· PMID 41545245mais citado
  6. Assessing rare disease understanding: a novel disease readiness level framework.
    Orphanet J Rare Dis· 2025· PMID 41466293recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:31150(Orphanet)
  2. OMIM OMIM:205400(OMIM)
  3. MONDO:0008783(MONDO)
  4. GARD:7731(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q1442621(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença de Tangier
Compêndio · Raras BR

Doença de Tangier

ORPHA:31150 · MONDO:0008783
Prevalência
<1 / 1 000 000
Casos
185 casos conhecidos
Herança
Autosomal recessive
CID-10
E78.6 · Deficiências de lipoproteínas
CID-11
Início
Adolescent, Adult, Childhood, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0039292
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades